Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
| Autor: | Schneeweiss, A. *, Huober, J., Sinn, H.-P., Fournier, D. von, Rudlowski, C., Beldermann, F., Krauss, K., Solomayer, E., Hamerla, R., Wallwiener, D., Bastert, G. |
|---|---|
| Zdroj: | In European Journal of Cancer 2004 40(16):2432-2438 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect